ESC 365 - Doctor David Hong

Speaker illustration

Doctor David Hong

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul (Korea (Republic of))

Member of:

Antiplatelet agents in patients with intermediate coronary artery stenosis and deferred revascularization

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Functional testing in coronary artery disease

Novel risk scoring model to assess the need for venoarterial-extracorporeal membrane oxygenation in patients with acute myocarditis

Event: ESC Congress 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Myocarditis: good tools for predicting bad outcomes

Prognosis after non-infarct related artery PCI in patients with acute myocardial infarction and multivessel disease: substudy of FRAME-AMI trial

Event: ESC Congress 2023

Topic: Intracoronary Flow and Pressure Measurements

Session: Intracoronary physiology in percutaneous coronary intervention

Fractional flow reserve and fractional flow reserve gradient from coronary CT angiography for future coronary events

Event: ESC Congress 2023

Topic: Noninvasive Imaging

Session: Intracoronary imaging/functional testing in acute coronary syndromes (1)

Clinical outcomes of deferred lesions by IVUS versus FFR-guided treatment decision: the FLAVOUR trial substudy

Event: ESC Congress 2023

Topic: Coronary Circulation, Flow, and Flow Reserve

Session: Imaging in chronic coronary syndrome

The association of multidisciplinary team approach with clinical outcomes in patients with acute myocardial infarction underwent veno-arterial extracorporeal membrane oxygenation

Event: ESC Congress 2019

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Coronary syndrome devices

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources